Reaching People, Changing Lives

At Aurinia Pharmaceuticals, we’re developing innovative products for patients living with debilitating diseases.

How We’re Helping Patients

Latest News

December 4, 2019 • 12:00am EST

Aurinia Announces Positive AURORA Phase 3 Trial Results Demonstrating Voclosporin Superiority Over Standard of Care in Lupus Nephritis

Read Press Release View All News

December 3, 2019 • 12:00am EST

Aurinia to Present Preclinical Voclosporin Data at 2020 Keystone Symposia Conference

Read Press Release View All News

November 14, 2019 • 12:00am EST

Aurinia Reports Third Quarter 2019 Financial Results and Recent Operational Highlights

Read Press Release View All News

Email Alerts

Stay informed and receive company updates straight to your inbox

Sign Up Today